NDC Product Labeler Horizon Therapeutics Usa, Inc.
Horizon Therapeutics Usa, Inc. labeler's code is 75987. The labeler has 20 products that have an assigned National Drug Code.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Product Type | Status |
|---|---|---|---|---|---|---|
| 75987-050 | Ravicti | Glycerol Phenylbutyrate | Liquid | Oral | Human Prescription Drug | ACTIVE |
| 75987-058 | Krystexxa | Pegloticase | Injection, Solution | Intravenous | Human Prescription Drug | ACTIVE |
| 75987-060 | Buphenyl | Sodium Phenylbutyrate | Tablet | Oral | Human Prescription Drug | ACTIVE |
| 75987-070 | Buphenyl | Sodium Phenylbutyrate | Powder | Oral | Human Prescription Drug | ACTIVE |
| 75987-080 | Krystexxa | Pegloticase | Injection, Solution | Intravenous | Human Prescription Drug | ACTIVE |
| 75987-100 | Procysbi | Cysteamine Bitartrate | Capsule, Delayed Release Pellets | Oral | Human Prescription Drug | ACTIVE |
| 75987-101 | Procysbi | Cysteamine Bitartrate | Capsule, Delayed Release Pellets | Oral | Human Prescription Drug | ACTIVE |
| 75987-111 | Actimmune | Interferon Gamma-1b | Injection, Solution | Subcutaneous | Human Prescription Drug | ACTIVE |
| 75987-130 | Tepezza | Teprotumumab | Injection, Powder, Lyophilized, For Solution | Intravenous | Human Prescription Drug | ACTIVE |
| 75987-140 | Procysbi | Cysteamine Bitartrate | Granule, Delayed Release | Oral | Human Prescription Drug | ACTIVE |
| 75987-145 | Procysbi | Cysteamine Bitartrate | Granule, Delayed Release | Oral | Human Prescription Drug | ACTIVE |
| 75987-150 | Uplizna | Inebilizumab | Injection | Intravenous | Human Prescription Drug | ACTIVE |
| 75987-010 | Duexis | |||||
| 75987-020 | Rayos | |||||
| 75987-021 | Rayos | |||||
| 75987-022 | Rayos | |||||
| 75987-030 | Vimovo | |||||
| 75987-031 | Vimovo | |||||
| 75987-040 | Pennsaid | |||||
| 75987-090 | Migergot | INACTIVATED |